Establishment Labs Holdings Inc. Common Shares (ESTA)

FairStock Score: 41/100 — MIXED

Key Financials

Strengths

• Revenue growth of 45.2% demonstrates strong top-line momentum

Concerns

• High leverage at 16.98x debt-to-equity increases financial risk and interest expense burden
• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration

AI Analysis

Establishment Labs Holdings Inc. Common Shares is a micro-cap healthcare company valued at $1.9 billion. Revenue stands at $230 million, though the company is currently unprofitable. From a quality standpoint, Establishment shows Altman Z-Score of 2.2 in the grey zone and negative ROE indicating losses. Growth dynamics show revenue growing at 45.2% and profit growth of 92.4%. Our composite FairStock Score of 41/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

Establishment's 45% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer